pharmacogenomics

phar·ma·co·ge·net·ics

(far'mă-kō-jĕ-net'iks), The study of genetically determined variations in responses to drugs in humans or in laboratory organisms. Synonym(s): pharmacogenomics

pharmacogenomics

(fär′mə-kō-jə-nō′mĭks)n. (used with a sing. verb) The study of inherited variations in genetic factors that influence a patient's metabolic response to a given drug, especially adverse side effects. Also called pharmacogenetics.

pharmacogenomics

The formal study of inherited genetic variations that dictate different drug responses. Pharmacogenomics explores the ways such variations can be used to predict responses to investigational products and plays an increasingly important role in drug discovery.

phar·ma·co·ge·net·ics

, pharmacogenomics (fahr'mă-kō-jĕ-net'iks, -nō'miks) The study of genetically determined variations in responses to drugs in humans or in laboratory organisms.

pharmacogenomics

The recognition of the fact and significance of human genetic variability in relation to drug action and its application to medical treatment. Genetic variability affects drug absorption, distribution, metabolism and excretion. As a result, many drugs which work very well in some people work poorly in others. At present, the best doctors can do is to prescribe a drug and then wait and see how well the patient responds. Fuller knowledge of pharmacogenomics will, in the future, allow more reliable treatment and avoid expensive waste.

pharmacogenomics

analysis of the effects of GENOMICS on drug responses. This involves all the pharmacologically active genes, how they manifest their variations, how they interact to produce PHENOTYPES, and how these phenotypes affect drug responses. DNA MICROARRAYS/CHIPS should be useful in determining how genetic variation influences individual responses to a given drug or class of drugs. A major aim is to personalize drugs, by adapting them specifically to an individual's own genetic make-up, so that they will be fully efficacious with no side effects.

单词	pharmacogenomics
释义	pharmacogenomics phar·ma·co·ge·no·mics P5252800 (fär′mə-kō-jə-nō′mĭks)n. (used with a sing. verb) The study of inherited variations in genetic factors that influence a patient's metabolic response to a given drug, especially adverse side effects. Also called pharmacogenetics. pharmacogenomics (ˌfɑːməkəʊdʒɪˈnɒmɪks) n (functioning as singular) 1. (Medicine) the study of human genetic variability in relation to drug action and its application to medical treatment2. (Genetics) the study of human genetic variability in relation to drug action and its application to medical treatment ˌpharmacogeˈnomic adj EncyclopediaSeepharmacogenetics pharmacogenomics phar·ma·co·ge·net·ics (far'mă-kō-jĕ-net'iks), The study of genetically determined variations in responses to drugs in humans or in laboratory organisms. Synonym(s): pharmacogenomics pharmacogenomics (fär′mə-kō-jə-nō′mĭks)n. (used with a sing. verb) The study of inherited variations in genetic factors that influence a patient's metabolic response to a given drug, especially adverse side effects. Also called pharmacogenetics. pharmacogenomics The formal study of inherited genetic variations that dictate different drug responses. Pharmacogenomics explores the ways such variations can be used to predict responses to investigational products and plays an increasingly important role in drug discovery. phar·ma·co·ge·net·ics , pharmacogenomics (fahr'mă-kō-jĕ-net'iks, -nō'miks) The study of genetically determined variations in responses to drugs in humans or in laboratory organisms. pharmacogenomics The recognition of the fact and significance of human genetic variability in relation to drug action and its application to medical treatment. Genetic variability affects drug absorption, distribution, metabolism and excretion. As a result, many drugs which work very well in some people work poorly in others. At present, the best doctors can do is to prescribe a drug and then wait and see how well the patient responds. Fuller knowledge of pharmacogenomics will, in the future, allow more reliable treatment and avoid expensive waste. pharmacogenomics analysis of the effects of GENOMICS on drug responses. This involves all the pharmacologically active genes, how they manifest their variations, how they interact to produce PHENOTYPES, and how these phenotypes affect drug responses. DNA MICROARRAYS/CHIPS should be useful in determining how genetic variation influences individual responses to a given drug or class of drugs. A major aim is to personalize drugs, by adapting them specifically to an individual's own genetic make-up, so that they will be fully efficacious with no side effects. AcronymsSeePGX
随便看	magnitude estimation of listening effort magnitude image magnitude method magnitude of an earthquake magnitude of a star magnitude of relative error magnitude of risk reduction magnitude-only fourier data magnitude ratio magnitude relation magnitudes magnitude system magnitudinous mag nl magno magnocellular magnocellular cell magnocellular neurosecretory cell magnocellular pathway magnocellular portion of the red nucleus magnocellular red nucleus magnocellular system magnocellular visual system magnochromite magnoferrite

pharmacogenomics

phar·ma·co·ge·no·mics

pharmacogenomics

pharmacogenomics

phar·ma·co·ge·net·ics

pharmacogenomics

pharmacogenomics

phar·ma·co·ge·net·ics

pharmacogenomics

pharmacogenomics